Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$904,963,170
-$34,737,027 QoQ
Shares Held
3,563,268
-7.3% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#71
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $4,791,103,609 across 11 Drug Manufacturers - General names. JNJ ranks #2 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,277,161 | $1,531,865,340 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
3,563,268 | $904,963,170 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
12,226,954 | $704,517,086 | |
| 4 | ABBV |
AbbVie Inc.
|
2,280,159 | $573,779,209 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,455,664 | $315,552,823 | |
| 6 | PFE |
Pfizer Inc
|
12,896,296 | $310,542,805 | |
| 7 | AMGN |
Amgen Inc
|
613,694 | $222,230,868 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,705,761 | $215,505,842 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $904,963,170 | 3,563,268 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $939,700,197 | 3,844,298 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $506,515,088 | 2,447,524 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $375,700,597 | 2,026,214 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $279,439,473 | 1,829,391 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $314,989,030 | 1,899,355 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $267,163,754 | 1,847,350 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $253,549,834 | 1,564,543 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $242,124,560 | 1,656,572 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $258,270,640 | 1,632,661 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $253,894,031 | 1,619,842 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $302,892,161 | 1,944,733 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $360,447,602 | 2,177,668 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $442,463,620 | 2,854,604 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $734,116,942 | 4,155,771 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $698,591,555 | 4,276,393 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $815,742,407 | 4,595,473 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $775,239,285 | 4,374,199 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $664,709,417 | 3,885,599 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $526,485,476 | 3,259,972 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $618,814,505 | 3,756,310 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $644,707,903 | 3,922,774 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $609,930,750 | 3,875,529 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $532,244,807 | 3,574,992 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $517,566,351 | 3,680,341 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $534,270,431 | 4,074,357 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||